Office of Clinical Site Oversight (OCSO)

The DAIDS Office of Clinical Site Oversight (OCSO) facilitates the clinical research of the DAIDS scientific programs by overseeing clinical sites associated with the NIAID-sponsored HIV/AIDS clinical trials networks. As such, they perform the following key functions:

• Oversees grants of network clinical trials units (CTU) and clinical research sites (CRS) that participate in the HIV/AIDS clinical trials networks
• Establishes new clinical sites around the world
• Evaluates and monitors the administration, finances, and performance of existing clinical sites
• Works with other government agencies, other Institutes at the National Institutes of Health, and the HIV/AIDS clinical trial networks
• Verifies that optimal safeguards are employed for participant safety and that high quality research practices are utilized
• Oversees the DAIDS clinical research standards, policies and procedures that are used by clinical sites
• Monitors clinical site progress of enrolling of underserved populations and ensuring community representation
• Organizes and/or participates in program and regional meetings as necessary

back to top